查找临床试验

已按「胆管癌」检索,对应国际通用词 cholangiocarcinoma

试验不在中国怎么办?

共找到 213 项正在招募的试验

数据更新于 00:19,每 5 分钟自动同步
正在招募II 期NCT05503797

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

United States、Australia、Canada、France、Germany 等 12 国

年龄 8 Years – 不限

Fore Biotherapeutics

正在招募II 期NCT07359820

A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement

United States、France、South Korea、Spain、United Kingdom

年龄 18 Years – 不限

Elevar Therapeutics

正在招募不适用中国有中心NCT07557225

18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors

China

年龄 18 Years – 不限

Peking University First Hospital

正在招募II 期中国有中心NCT06721286

Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma

China

年龄 18 Years – 不限

Tianjin Medical University Cancer Institute and Hospital

正在招募不适用中国有中心NCT06462742

Microwave Ablation Versus Liver Resection for Intrahepatic Cholangiocarcinoma

China

年龄 18 Years – 不限

Chinese PLA General Hospital

正在招募不适用NCT06125769

LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma (LITALHICA)

Italy

年龄 18 Years – 70 Years

Azienda Sanitaria Ospedaliera

正在招募II 期中国有中心NCT06925516

A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC

China

年龄 18 Years – 75 Years

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

正在招募II 期NCT03364530

Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma

France

年龄 18 Years – 不限

University Hospital, Montpellier

正在招募II 期中国有中心NCT05557578

GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence

China

年龄 18 Years – 75 Years

Zhejiang Cancer Hospital

正在招募II 期NCT07201519

Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy

United States

年龄 18 Years – 99 Years

Michael J Cavnar, MD

正在招募I 期中国有中心NCT07213791

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

United States、China、Germany、Japan、Netherlands

年龄 18 Years – 不限

Eli Lilly and Company

正在招募不适用中国有中心NCT07744087

Modified Single-Incision Plus One-Port Versus Conventional Five-Port Laparoscopic Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas

China

年龄 18 Years – 75 Years

Nanfang Hospital, Southern Medical University